160 related articles for article (PubMed ID: 19716164)
1. Reg IV expression and clinicopathologic features of gallbladder carcinoma.
Tamura H; Ohtsuka M; Washiro M; Kimura F; Shimizu H; Yoshidome H; Kato A; Seki N; Miyazaki M
Hum Pathol; 2009 Dec; 40(12):1686-92. PubMed ID: 19716164
[TBL] [Abstract][Full Text] [Related]
2. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
[TBL] [Abstract][Full Text] [Related]
4. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.
Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T
Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032
[TBL] [Abstract][Full Text] [Related]
5. Expression of homeodomain protein CDX2 in gallbladder carcinomas.
Wu XS; Akiyama Y; Igari T; Kawamura T; Hiranuma S; Shibata T; Tsuruta K; Koike M; Arii S; Yuasa Y
J Cancer Res Clin Oncol; 2005 May; 131(5):271-8. PubMed ID: 15645288
[TBL] [Abstract][Full Text] [Related]
6. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
7. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.
Hughes NR; Bhathal PS
J Clin Pathol; 2013 Mar; 66(3):212-7. PubMed ID: 23268317
[TBL] [Abstract][Full Text] [Related]
9. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.
Yang L; Lan S; Liu J; Yang Z
Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336
[TBL] [Abstract][Full Text] [Related]
10. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Pathol Res Pract; 2011 Aug; 207(8):472-8. PubMed ID: 21719208
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
Hayashi T; Matsubara A; Ohara S; Mita K; Hasegawa Y; Usui T; Arihiro K; Norimura S; Sentani K; Oue N; Yasui W
Oncol Rep; 2009 Jan; 21(1):95-100. PubMed ID: 19082448
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis.
Oue N; Kuniyasu H; Noguchi T; Sentani K; Ito M; Tanaka S; Setoyama T; Sakakura C; Natsugoe S; Yasui W
Oncology; 2007; 72(5-6):371-80. PubMed ID: 18187959
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.
Bai YQ; Yamamoto H; Akiyama Y; Tanaka H; Takizawa T; Koike M; Kenji Yagi O; Saitoh K; Takeshita K; Iwai T; Yuasa Y
Cancer Lett; 2002 Feb; 176(1):47-55. PubMed ID: 11790453
[TBL] [Abstract][Full Text] [Related]
15. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
[TBL] [Abstract][Full Text] [Related]
16. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
17. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
19. A close relationship between intestinal metaplasia and Cdx2 expression in human gallbladders with cholelithiasis.
Sakamoto H; Mutoh H; Ido K; Satoh K; Hayakawa H; Sugano K
Hum Pathol; 2007 Jan; 38(1):66-71. PubMed ID: 16996572
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.
Prince S; Zeidman A; Dekel Y; Ram E; Koren R
Am J Clin Pathol; 2008 Mar; 129(3):424-9. PubMed ID: 18285265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
